Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study

Aim: Perform a comparison between adalimumab (ADA) and infliximab (IFX) in treating post-operative recurrence of Crohn's disease (a comparative analysis of efficacy and safety). Methods: From the 267 patients treated with adalimumab or infliximab between January 2005 and June 2014 in Romania, 4...

Full description

Bibliographic Details
Main Authors: Carmen-Monica Preda, Larisa-Elena Fulger, Lucian Negreanu, Mircea Manuc, Irina Sandra, Mircea Diculescu
Format: Article
Language:English
Published: Aran Ediciones
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016001000006&lng=en&tlng=en